Identification of a rare E6A2 fusion transcript, a variant BCR-ABL1 FISH pattern and cytogenetic evolution in a CML patient who was resistant to Gleevec but responded to AMN107 therapy
Publication
, Conference
Sebastian, S; Naber, JM; Kearney, HM; Lagoo, AS; Gong, JZ; Buckley, PJ; Gockerman, JP; Goodman, BK
Published in: JOURNAL OF MOLECULAR DIAGNOSTICS
November 1, 2006
Duke Scholars
Published In
JOURNAL OF MOLECULAR DIAGNOSTICS
ISSN
1525-1578
Publication Date
November 1, 2006
Volume
8
Issue
5
Start / End Page
638 / 638
Location
Orlando, FL
Publisher
AMER SOC INVESTIGATIVE PATHOLOGY, INC
Conference Name
Annual Meeting of the Association-for-Molecular-Pathology
Related Subject Headings
- Pathology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1108 Medical Microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sebastian, S., Naber, J. M., Kearney, H. M., Lagoo, A. S., Gong, J. Z., Buckley, P. J., … Goodman, B. K. (2006). Identification of a rare E6A2 fusion transcript, a variant BCR-ABL1 FISH pattern and cytogenetic evolution in a CML patient who was resistant to Gleevec but responded to AMN107 therapy. In JOURNAL OF MOLECULAR DIAGNOSTICS (Vol. 8, pp. 638–638). Orlando, FL: AMER SOC INVESTIGATIVE PATHOLOGY, INC.
Sebastian, S., J. M. Naber, H. M. Kearney, A. S. Lagoo, J. Z. Gong, P. J. Buckley, J. P. Gockerman, and B. K. Goodman. “Identification of a rare E6A2 fusion transcript, a variant BCR-ABL1 FISH pattern and cytogenetic evolution in a CML patient who was resistant to Gleevec but responded to AMN107 therapy.” In JOURNAL OF MOLECULAR DIAGNOSTICS, 8:638–638. AMER SOC INVESTIGATIVE PATHOLOGY, INC, 2006.
Sebastian S, Naber JM, Kearney HM, Lagoo AS, Gong JZ, Buckley PJ, et al. Identification of a rare E6A2 fusion transcript, a variant BCR-ABL1 FISH pattern and cytogenetic evolution in a CML patient who was resistant to Gleevec but responded to AMN107 therapy. In: JOURNAL OF MOLECULAR DIAGNOSTICS. AMER SOC INVESTIGATIVE PATHOLOGY, INC; 2006. p. 638–638.
Sebastian, S., et al. “Identification of a rare E6A2 fusion transcript, a variant BCR-ABL1 FISH pattern and cytogenetic evolution in a CML patient who was resistant to Gleevec but responded to AMN107 therapy.” JOURNAL OF MOLECULAR DIAGNOSTICS, vol. 8, no. 5, AMER SOC INVESTIGATIVE PATHOLOGY, INC, 2006, pp. 638–638.
Sebastian S, Naber JM, Kearney HM, Lagoo AS, Gong JZ, Buckley PJ, Gockerman JP, Goodman BK. Identification of a rare E6A2 fusion transcript, a variant BCR-ABL1 FISH pattern and cytogenetic evolution in a CML patient who was resistant to Gleevec but responded to AMN107 therapy. JOURNAL OF MOLECULAR DIAGNOSTICS. AMER SOC INVESTIGATIVE PATHOLOGY, INC; 2006. p. 638–638.
Published In
JOURNAL OF MOLECULAR DIAGNOSTICS
ISSN
1525-1578
Publication Date
November 1, 2006
Volume
8
Issue
5
Start / End Page
638 / 638
Location
Orlando, FL
Publisher
AMER SOC INVESTIGATIVE PATHOLOGY, INC
Conference Name
Annual Meeting of the Association-for-Molecular-Pathology
Related Subject Headings
- Pathology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1108 Medical Microbiology